Diabetic foot infections: Questions for an infectious disease consultant

Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious dise...

Full description

Saved in:
Bibliographic Details
Published inSeminars in vascular surgery Vol. 38; no. 1; pp. 85 - 93
Main Authors Nauriyal, Varidhi, Byers, Karin
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2025
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.
AbstractList Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.
ABSTRACTDiabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.
Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot infection, the goal of limb preservation is best achieved with a multidisciplinary approach and a team of providers including infectious disease consultants. However, these infections often affect populations living in nonmetropolitan areas, where access to an infectious disease physician may be limited. It may fall on the surgeons and primary care providers to not only diagnose infections early, including osteomyelitis, but also facilitate prompt, appropriate antibiotic management. The decision to treat with antibiotics alone versus surgery, choice of antibiotic, route of administration, and duration of treatment are complicated concepts that require a patient-specific approach. In addition, use of oral antibiotics and long-acting lipoglycopeptides has gained prominence and offers an alternate solution to the tedious, resource-intense process of outpatient intravenous antibiotic treatment. The goal of this article is to outline and address diagnostic and management questions that would be posed to an infectious disease consultant. The responses would include a literature review of current management concepts and highlights from the 2023 Infectious Disease Society of America and International Working Group on the Diabetic Foot guidelines.
Author Nauriyal, Varidhi
Byers, Karin
Author_xml – sequence: 1
  givenname: Varidhi
  surname: Nauriyal
  fullname: Nauriyal, Varidhi
  email: nauriyalv@upmc.edu
  organization: Divisions of Infectious Disease and Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, University of Pittsburgh Medical Center, 3601 Fifth Avenue, Falk Medical Building, 7th Floor, Pittsburgh, PA 15213
– sequence: 2
  givenname: Karin
  surname: Byers
  fullname: Byers, Karin
  organization: Division of Infectious Disease, Department of Internal Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40086926$$D View this record in MEDLINE/PubMed
BookMark eNqNkV9rFTEQxYNU7G31K8j65suuk9xkk_gglOufCgUR9Tlks7OS695szewW-u3NemsRQehTAufM4cxvzthJmhIy9oJDw0FtX-0bwsONp0BL_t4IEKoB3gDYR2zDlTK1VNycsA0Yq2ptW33Kzoj2AKJthX7CTiWAaa1oN-zybfQdzjFUwzTNVUwDhjlOiV5Xnxek398i5cqne3Ghqo-EnrAKRV7G2af5KXs8-JHw2d17zr69f_d1d1lfffrwcXdxVYdtK-faKxCik9ANvUVlWgmlh9eog--96oyRerDYAnrQRgbspTK-68LQWWtAi-05e3nMvc7Tz7WhO0QKOI4-YWnmtlxrabjitlif31mX7oC9u87x4POt-7N9MdijIeSJKONwb-HgVtJu7_4i7VbSDrgrpMvs7jiLZdmbiNlRiJhK45gLJddP8UEpb_5JCWNMMfjxB94i7aclp0LTcUfCgfuyXnQ9qFAAwDmUgIv_BzywxC8mrbj0
Cites_doi 10.1111/dme.13537
10.1053/j.jfas.2011.08.005
10.1002/dmrr.3250
10.1086/380449
10.1016/0002-9343(87)90894-1
10.1093/cid/ciw445
10.1111/j.1464-5491.2010.03150.x
10.1007/s00125-008-0940-0
10.1093/cid/cis346
10.1053/j.jfas.2006.04.002
10.3310/hta23610
10.4084/MJHID.2022.055
10.1093/clind/24.4.643
10.1093/ofid/ofy331
10.1080/07853890.2016.1231932
10.1056/NEJMoa1710926
10.1086/498112
10.2337/dc13-1526
10.1086/511036
10.1001/jama.2023.10578
10.1186/s13063-021-05472-6
10.2337/dc14-1514
10.1016/j.jcot.2020.12.014
10.1016/j.ejvs.2019.03.040
10.1002/dmrr.2425
10.1093/ofid/ofaa393
10.1007/s00125-006-0491-1
10.2337/dci22-0043
10.1093/cid/ciaa1758
10.1007/s10096-019-03547-6
10.1001/jamanetworkopen.2022.11321
10.1002/dmrr.3686
10.1001/jamanetworkopen.2019.16003
ContentType Journal Article
Copyright 2025 Elsevier Inc.
Elsevier Inc.
Copyright © 2025 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2025 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2025 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1053/j.semvascsurg.2025.01.009
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1558-4518
EndPage 93
ExternalDocumentID 40086926
10_1053_j_semvascsurg_2025_01_009
S0895796725000110
1_s2_0_S0895796725000110
Genre Journal Article
Review
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
123
1B1
1P~
1~.
1~5
4.4
457
4G.
53G
5VS
7-5
71M
8P~
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFRF
ABJNI
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OK-
OW-
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SDF
SDG
SEL
SES
SPCBC
SSH
SSZ
T5K
UNMZH
Z5R
ZGI
~G-
AFCTW
AGRNS
AACTN
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c364t-a5022b40bfd9e58640692a7e7cada5b8847f9e60ea0784ced458abbcfb9980723
IEDL.DBID .~1
ISSN 0895-7967
1558-4518
IngestDate Thu Aug 07 14:14:53 EDT 2025
Thu May 15 23:18:57 EDT 2025
Tue Jul 01 05:07:56 EDT 2025
Sat May 03 15:55:14 EDT 2025
Fri May 16 03:43:10 EDT 2025
Tue Aug 26 18:14:54 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Osteomyelitis
Infectious
Diabetes
Antibiotics
Guidelines
Language English
License Copyright © 2025 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c364t-a5022b40bfd9e58640692a7e7cada5b8847f9e60ea0784ced458abbcfb9980723
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
PMID 40086926
PQID 3177481519
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_3177481519
pubmed_primary_40086926
crossref_primary_10_1053_j_semvascsurg_2025_01_009
elsevier_sciencedirect_doi_10_1053_j_semvascsurg_2025_01_009
elsevier_clinicalkeyesjournals_1_s2_0_S0895796725000110
elsevier_clinicalkey_doi_10_1053_j_semvascsurg_2025_01_009
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-03-01
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Seminars in vascular surgery
PublicationTitleAlternate Semin Vasc Surg
PublicationYear 2025
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Zhang, Lu, Jing (bib0002) 2017; 49
Schechter, Ali, Risk (bib0019) 2020; 7
Lipsky, Berendt, Cornia (bib0026) 2012; 54
Sr, MS, Armstrong (bib0007) 2014; 59
Senneville, Lipsky, van Asten (bib0015) 2020; 36
Senneville, Melliez, Beltrand (bib0016) 2006; 42
Ndosi, Wright-Hughes, Brown (bib0004) 2018; 35
Lam, van Asten, Nguyen (bib0010) 2016; 63
Meyr, Singh, Zhang (bib0020) 2011; 50
Lázaro-Martínez, García-Madrid, García-Álvarez (bib0032) 2020; 16
Aragón-Sánchez, Lipsky, JL (bib0013) 2011; 28
Wilson, Bessesen, Doros (bib0028) 2019; 2
van Reijen, Ponchant, Ubbink (bib0008) 2019; 58
FDA approves Dalvance to treat skin infections [press release]. US Food and Drug Administration. May 23, 2014.
Armstrong, Tan, Boulton (bib0009) 2023; 330
Prompers, Huijberts, Apelqvist (bib0033) 2007; 50
Rappo, Puttagunta, Shevchenko (bib0037) 2019; 6
Senneville, Albalawi, van Asten (bib0005) 2023; 79
Accessed 10/10/2024.
McDermott, Fang, Boulton (bib0003) 2023; 46
Gramberg, Lagrand, Sabelis (bib0021) 2021; 22
Prompers, Schaper, Apelqvist (bib0034) 2008; 51
Lavery, Armstrong, Murdoch (bib0006) 2007; 44
Lipsky, Itani, Norden (bib0029) 2004; 38
Spellberg, Aggrey, Brennan (bib0022) 2022; 5
Fitridge, Chuter, Mills (bib0035) 2024; 40
Llewellyn, Jones-Diette, Kraft (bib0011) 2019; 23
Leone, Bianco, D'Ambra (bib0012) 2022; 14
Faglia, Clerici, Caminiti (bib0031) 2006; 45
Tone, Nguyen, Devemy (bib0024) 2015; 38
Gariani, Pham, Kressmann (bib0025) 2020; 73
Accessed 2/16/2024.
Malone, Bowling, Gannass (bib0017) 2013; 29
Bamberger, Daus, Gerding (bib0030) 1987; 83
Lázaro-Martínez, Aragon-Sanchez, Garcia-Morales (bib0023) 2014; 37
Li, Rombach, Zambellas (bib0027) 2019; 380
National diabetes statistics report. Centers for Disease Control and Prevention.
Lipsky, Baker, Landon (bib0014) 1997; 24
Couturier, Chabaud, Desbiez (bib0018) 2019; 38
Zhang (10.1053/j.semvascsurg.2025.01.009_bib0002) 2017; 49
Lázaro-Martínez (10.1053/j.semvascsurg.2025.01.009_bib0023) 2014; 37
Lavery (10.1053/j.semvascsurg.2025.01.009_bib0006) 2007; 44
Prompers (10.1053/j.semvascsurg.2025.01.009_bib0034) 2008; 51
van Reijen (10.1053/j.semvascsurg.2025.01.009_bib0008) 2019; 58
Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0029) 2004; 38
Llewellyn (10.1053/j.semvascsurg.2025.01.009_bib0011) 2019; 23
Gariani (10.1053/j.semvascsurg.2025.01.009_bib0025) 2020; 73
Spellberg (10.1053/j.semvascsurg.2025.01.009_bib0022) 2022; 5
Sr (10.1053/j.semvascsurg.2025.01.009_bib0007) 2014; 59
Armstrong (10.1053/j.semvascsurg.2025.01.009_bib0009) 2023; 330
Schechter (10.1053/j.semvascsurg.2025.01.009_bib0019) 2020; 7
Lázaro-Martínez (10.1053/j.semvascsurg.2025.01.009_bib0032) 2020; 16
Meyr (10.1053/j.semvascsurg.2025.01.009_bib0020) 2011; 50
Gramberg (10.1053/j.semvascsurg.2025.01.009_bib0021) 2021; 22
Rappo (10.1053/j.semvascsurg.2025.01.009_bib0037) 2019; 6
Prompers (10.1053/j.semvascsurg.2025.01.009_bib0033) 2007; 50
Couturier (10.1053/j.semvascsurg.2025.01.009_bib0018) 2019; 38
10.1053/j.semvascsurg.2025.01.009_bib0001
Senneville (10.1053/j.semvascsurg.2025.01.009_bib0005) 2023; 79
Ndosi (10.1053/j.semvascsurg.2025.01.009_bib0004) 2018; 35
Senneville (10.1053/j.semvascsurg.2025.01.009_bib0016) 2006; 42
Wilson (10.1053/j.semvascsurg.2025.01.009_bib0028) 2019; 2
10.1053/j.semvascsurg.2025.01.009_bib0036
Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0026) 2012; 54
Lipsky (10.1053/j.semvascsurg.2025.01.009_bib0014) 1997; 24
Bamberger (10.1053/j.semvascsurg.2025.01.009_bib0030) 1987; 83
Lam (10.1053/j.semvascsurg.2025.01.009_bib0010) 2016; 63
Malone (10.1053/j.semvascsurg.2025.01.009_bib0017) 2013; 29
Li (10.1053/j.semvascsurg.2025.01.009_bib0027) 2019; 380
Fitridge (10.1053/j.semvascsurg.2025.01.009_bib0035) 2024; 40
Leone (10.1053/j.semvascsurg.2025.01.009_bib0012) 2022; 14
Faglia (10.1053/j.semvascsurg.2025.01.009_bib0031) 2006; 45
Aragón-Sánchez (10.1053/j.semvascsurg.2025.01.009_bib0013) 2011; 28
McDermott (10.1053/j.semvascsurg.2025.01.009_bib0003) 2023; 46
Senneville (10.1053/j.semvascsurg.2025.01.009_bib0015) 2020; 36
Tone (10.1053/j.semvascsurg.2025.01.009_bib0024) 2015; 38
References_xml – volume: 2
  year: 2019
  ident: bib0028
  article-title: Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration
  publication-title: JAMA Netw Open
– volume: 51
  start-page: 747
  year: 2008
  end-page: 755
  ident: bib0034
  article-title: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study
  publication-title: Diabetologia
– volume: 6
  start-page: ofy331
  year: 2019
  ident: bib0037
  article-title: Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety
  publication-title: Open Forum Infect Dis
– volume: 42
  start-page: 57
  year: 2006
  end-page: 62
  ident: bib0016
  article-title: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures
  publication-title: Clin Infect Dis
– volume: 23
  start-page: 1
  year: 2019
  end-page: 128
  ident: bib0011
  article-title: Imaging tests for the detection of osteomyelitis: a systematic review
  publication-title: Health Technol Assess
– volume: 14
  year: 2022
  ident: bib0012
  article-title: The role of serial radiographs in diagnosing diabetic foot bone osteomyelitis
  publication-title: Mediterr J Hematol Infect Dis
– reference: , Accessed 2/16/2024.
– volume: 63
  start-page: 944
  year: 2016
  end-page: 948
  ident: bib0010
  article-title: Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review
  publication-title: Clin Infect Dis
– volume: 29
  start-page: 546
  year: 2013
  end-page: 550
  ident: bib0017
  article-title: Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis
  publication-title: Diabetes Metab Res Rev
– volume: 28
  start-page: 191
  year: 2011
  end-page: 194
  ident: bib0013
  article-title: Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?
  publication-title: Diabet Med
– volume: 50
  start-page: 663
  year: 2011
  end-page: 667
  ident: bib0020
  article-title: Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis
  publication-title: J Foot Ankle Surg
– reference: , Accessed 10/10/2024.
– reference: National diabetes statistics report. Centers for Disease Control and Prevention.
– volume: 49
  start-page: 106
  year: 2017
  end-page: 116
  ident: bib0002
  article-title: Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
  publication-title: Ann Med
– volume: 73
  start-page: e1539
  year: 2020
  end-page: e1545
  ident: bib0025
  article-title: Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, non-inferiority pilot trial
  publication-title: Clin Infect Dis
– volume: 54
  start-page: e132
  year: 2012
  end-page: e173
  ident: bib0026
  article-title: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections
  publication-title: Clin Infect Dis
– volume: 380
  start-page: 425
  year: 2019
  end-page: 436
  ident: bib0027
  article-title: Oral versus intravenous antibiotics for bone and joint infection
  publication-title: N Engl J Med
– volume: 50
  start-page: 18
  year: 2007
  end-page: 25
  ident: bib0033
  article-title: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study
  publication-title: Diabetologia
– volume: 36
  start-page: e3250
  year: 2020
  ident: bib0015
  article-title: Diagnosing diabetic foot osteomyelitis
  publication-title: Diabetes Metab Res Rev
– volume: 40
  start-page: e3686
  year: 2024
  ident: bib0035
  article-title: The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer
  publication-title: Diabetes Metab Res Rev
– volume: 5
  year: 2022
  ident: bib0022
  article-title: Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines Group Consensus Statement
  publication-title: JAMA Netw Open
– volume: 58
  start-page: 362
  year: 2019
  end-page: 371
  ident: bib0008
  article-title: The prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis
  publication-title: Eur J Vasc Endovasc Surg
– volume: 38
  start-page: 302
  year: 2015
  end-page: 307
  ident: bib0024
  article-title: Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study
  publication-title: Diabetes Care
– volume: 7
  start-page: ofaa393
  year: 2020
  ident: bib0019
  article-title: Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis
  publication-title: Open Forum Infect Dis
– volume: 22
  start-page: 517
  year: 2021
  ident: bib0021
  article-title: Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial
  publication-title: Trials
– reference: FDA approves Dalvance to treat skin infections [press release]. US Food and Drug Administration. May 23, 2014.
– volume: 59
  year: 2014
  ident: bib0007
  article-title: The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)
  publication-title: J Vasc Surg
– volume: 24
  start-page: 643
  year: 1997
  end-page: 648
  ident: bib0014
  article-title: Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens
  publication-title: Clin Infect Dis
– volume: 83
  start-page: 653
  year: 1987
  end-page: 660
  ident: bib0030
  article-title: Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy
  publication-title: Am J Med
– volume: 46
  start-page: 209
  year: 2023
  end-page: 221
  ident: bib0003
  article-title: Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
  publication-title: Diabetes Care
– volume: 330
  start-page: 62
  year: 2023
  end-page: 75
  ident: bib0009
  article-title: Diabetic foot ulcers: a review
  publication-title: JAMA
– volume: 38
  start-page: 1287
  year: 2019
  end-page: 1291
  ident: bib0018
  article-title: Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study
  publication-title: Eur J Clin Microbiol Infect Dis
– volume: 37
  start-page: 789
  year: 2014
  end-page: 795
  ident: bib0023
  article-title: Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial
  publication-title: Diabetes Care
– volume: 79
  start-page: 286
  year: 2023
  ident: bib0005
  article-title: IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023)
  publication-title: Clin Infect Dis
– volume: 44
  start-page: 562
  year: 2007
  end-page: 565
  ident: bib0006
  article-title: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system
  publication-title: Clin Infect Dis
– volume: 38
  start-page: 17
  year: 2004
  end-page: 24
  ident: bib0029
  article-title: Linezolid diabetic foot infections study group, treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate
  publication-title: Clin Infect Dis
– volume: 45
  start-page: 220
  year: 2006
  end-page: 226
  ident: bib0031
  article-title: The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes
  publication-title: J Foot Ankle Surg
– volume: 35
  start-page: 78
  year: 2018
  end-page: 88
  ident: bib0004
  article-title: Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study
  publication-title: Diabet Med
– volume: 16
  start-page: 86
  year: 2020
  end-page: 98
  ident: bib0032
  article-title: Conservative surgery for chronic diabetic foot osteomyelitis: procedures and recommendations
  publication-title: J Clin Orthop Trauma
– volume: 35
  start-page: 78
  year: 2018
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0004
  article-title: Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study
  publication-title: Diabet Med
  doi: 10.1111/dme.13537
– volume: 50
  start-page: 663
  year: 2011
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0020
  article-title: Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis
  publication-title: J Foot Ankle Surg
  doi: 10.1053/j.jfas.2011.08.005
– volume: 36
  start-page: e3250
  issue: suppl 1
  year: 2020
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0015
  article-title: Diagnosing diabetic foot osteomyelitis
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.3250
– volume: 38
  start-page: 17
  year: 2004
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0029
  article-title: Linezolid diabetic foot infections study group, treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate
  publication-title: Clin Infect Dis
  doi: 10.1086/380449
– volume: 83
  start-page: 653
  year: 1987
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0030
  article-title: Osteomyelitis in the feet of diabetic patients. Long-term results, prognostic factors, and the role of antimicrobial and surgical therapy
  publication-title: Am J Med
  doi: 10.1016/0002-9343(87)90894-1
– volume: 63
  start-page: 944
  year: 2016
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0010
  article-title: Diagnostic accuracy of probe to bone to detect osteomyelitis in the diabetic foot: a systematic review
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciw445
– volume: 28
  start-page: 191
  year: 2011
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0013
  article-title: Diagnosing diabetic foot osteomyelitis: is the combination of probe-to-bone test and plain radiography sufficient for high-risk inpatients?
  publication-title: Diabet Med
  doi: 10.1111/j.1464-5491.2010.03150.x
– volume: 51
  start-page: 747
  year: 2008
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0034
  article-title: Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study
  publication-title: Diabetologia
  doi: 10.1007/s00125-008-0940-0
– volume: 54
  start-page: e132
  year: 2012
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0026
  article-title: Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/cis346
– volume: 45
  start-page: 220
  year: 2006
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0031
  article-title: The role of early surgical debridement and revascularization in patients with diabetes and deep foot space abscess: retrospective review of 106 patients with diabetes
  publication-title: J Foot Ankle Surg
  doi: 10.1053/j.jfas.2006.04.002
– volume: 23
  start-page: 1
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0011
  article-title: Imaging tests for the detection of osteomyelitis: a systematic review
  publication-title: Health Technol Assess
  doi: 10.3310/hta23610
– volume: 14
  year: 2022
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0012
  article-title: The role of serial radiographs in diagnosing diabetic foot bone osteomyelitis
  publication-title: Mediterr J Hematol Infect Dis
  doi: 10.4084/MJHID.2022.055
– volume: 24
  start-page: 643
  year: 1997
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0014
  article-title: Antibiotic therapy for diabetic foot infections: comparison of two parenteral-to-oral regimens
  publication-title: Clin Infect Dis
  doi: 10.1093/clind/24.4.643
– volume: 79
  start-page: 286
  year: 2023
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0005
  article-title: IWGDF/IDSA guidelines on the diagnosis and treatment of diabetes-related foot infections (IWGDF/IDSA 2023)
  publication-title: Clin Infect Dis
– volume: 6
  start-page: ofy331
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0037
  article-title: Dalbavancin for the treatment of osteomyelitis in adult patients: a randomized clinical trial of efficacy and safety
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofy331
– volume: 49
  start-page: 106
  year: 2017
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0002
  article-title: Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis
  publication-title: Ann Med
  doi: 10.1080/07853890.2016.1231932
– volume: 380
  start-page: 425
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0027
  article-title: Oral versus intravenous antibiotics for bone and joint infection
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1710926
– volume: 42
  start-page: 57
  year: 2006
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0016
  article-title: Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures
  publication-title: Clin Infect Dis
  doi: 10.1086/498112
– volume: 37
  start-page: 789
  year: 2014
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0023
  article-title: Antibiotics versus conservative surgery for treating diabetic foot osteomyelitis: a randomized comparative trial
  publication-title: Diabetes Care
  doi: 10.2337/dc13-1526
– volume: 44
  start-page: 562
  year: 2007
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0006
  article-title: Validation of the Infectious Diseases Society of America's diabetic foot infection classification system
  publication-title: Clin Infect Dis
  doi: 10.1086/511036
– ident: 10.1053/j.semvascsurg.2025.01.009_bib0001
– volume: 330
  start-page: 62
  year: 2023
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0009
  article-title: Diabetic foot ulcers: a review
  publication-title: JAMA
  doi: 10.1001/jama.2023.10578
– volume: 22
  start-page: 517
  year: 2021
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0021
  article-title: Using a BonE BiOPsy (BeBoP) to determine the causative agent in persons with diabetes and foot osteomyelitis: study protocol for a multicentre, randomised controlled trial
  publication-title: Trials
  doi: 10.1186/s13063-021-05472-6
– ident: 10.1053/j.semvascsurg.2025.01.009_bib0036
– volume: 38
  start-page: 302
  year: 2015
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0024
  article-title: Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study
  publication-title: Diabetes Care
  doi: 10.2337/dc14-1514
– volume: 16
  start-page: 86
  year: 2020
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0032
  article-title: Conservative surgery for chronic diabetic foot osteomyelitis: procedures and recommendations
  publication-title: J Clin Orthop Trauma
  doi: 10.1016/j.jcot.2020.12.014
– volume: 58
  start-page: 362
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0008
  article-title: The prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis
  publication-title: Eur J Vasc Endovasc Surg
  doi: 10.1016/j.ejvs.2019.03.040
– volume: 59
  year: 2014
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0007
  article-title: The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI)
  publication-title: J Vasc Surg
– volume: 29
  start-page: 546
  year: 2013
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0017
  article-title: Deep wound cultures correlate well with bone biopsy culture in diabetic foot osteomyelitis
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.2425
– volume: 7
  start-page: ofaa393
  year: 2020
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0019
  article-title: Percutaneous bone biopsy for diabetic foot osteomyelitis: a systematic review and meta-analysis
  publication-title: Open Forum Infect Dis
  doi: 10.1093/ofid/ofaa393
– volume: 50
  start-page: 18
  year: 2007
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0033
  article-title: High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study
  publication-title: Diabetologia
  doi: 10.1007/s00125-006-0491-1
– volume: 46
  start-page: 209
  year: 2023
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0003
  article-title: Etiology, epidemiology, and disparities in the burden of diabetic foot ulcers
  publication-title: Diabetes Care
  doi: 10.2337/dci22-0043
– volume: 73
  start-page: e1539
  year: 2020
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0025
  article-title: Three versus six weeks of antibiotic therapy for diabetic foot osteomyelitis: a prospective, randomized, non-inferiority pilot trial
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciaa1758
– volume: 38
  start-page: 1287
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0018
  article-title: Comparison of microbiological results obtained from per-wound bone biopsies versus transcutaneous bone biopsies in diabetic foot osteomyelitis: a prospective cohort study
  publication-title: Eur J Clin Microbiol Infect Dis
  doi: 10.1007/s10096-019-03547-6
– volume: 5
  year: 2022
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0022
  article-title: Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a WikiGuidelines Group Consensus Statement
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2022.11321
– volume: 40
  start-page: e3686
  year: 2024
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0035
  article-title: The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer
  publication-title: Diabetes Metab Res Rev
  doi: 10.1002/dmrr.3686
– volume: 2
  year: 2019
  ident: 10.1053/j.semvascsurg.2025.01.009_bib0028
  article-title: Adjunctive rifampin therapy for diabetic foot osteomyelitis in the Veterans Health Administration
  publication-title: JAMA Netw Open
  doi: 10.1001/jamanetworkopen.2019.16003
SSID ssj0026627
Score 2.3895845
SecondaryResourceType review_article
Snippet Diabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with diabetic foot...
ABSTRACTDiabetic foot infection can lead to limb amputation in approximately 17% of affected patients. Given the complex pathophysiology associated with...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 85
SubjectTerms Amputation, Surgical
Anti-Bacterial Agents - administration & dosage
Anti-Bacterial Agents - adverse effects
Antibiotics
Clinical Decision-Making
Consultants
Diabetes
Diabetic Foot - diagnosis
Diabetic Foot - microbiology
Diabetic Foot - therapy
Guidelines
Humans
Infectious
Limb Salvage
Osteomyelitis
Patient Care Team
Referral and Consultation
Risk Factors
Surgery
Treatment Outcome
Title Diabetic foot infections: Questions for an infectious disease consultant
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0895796725000110
https://www.clinicalkey.es/playcontent/1-s2.0-S0895796725000110
https://dx.doi.org/10.1053/j.semvascsurg.2025.01.009
https://www.ncbi.nlm.nih.gov/pubmed/40086926
https://www.proquest.com/docview/3177481519
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3ZS8MwGA9jgvgiitc8Rge-1nVp0mP4MoZjXkPUwd5C0iYy0G6s3at_u9_XYyhOGPjUIwkpv3z5jn5HCLmEDcZDzzCbRZ3AZlyGtmQRxj-ZGMS7G0cSE4UfR95wzO4mfFIj_SoXBsMqS95f8PScW5dv2iWa7fl02n5xAnQxeT7luWKDdjtjPlL51ecqzINigfNckwyxNKPnb5NWcbqt28as7g8M-EyXizcwFWlRwRNjE9fLqL900FwWDfbIbqlEWr3iO_dJTScHZFgEt0wjy8xmmVVFWSVp18r_auItNC0smawal6lVemisCHMx3_FM4UMyHty89od2eU6CHbkey2zJQRAr5igTh5oHHiazUulrP5Kx5CoAAWRC7Tlagj7AAFjGA6lUZBTYWo5P3SNST2aJPiGWkWAOBhyMMm0Y8GTluDDAgFYF_WisGoRWyIh5UQ5D5G5s7oIZ8Q1OgXAKpyMAzgbpVhiKKt8TOJQApr3JYH_dYJ2Wey0VHZFS4Yhf9NAg16uRP0hq04lb1XIL2HLoR5GJhoURoHL5WOOmA32OCzpYgcHQRgypd_q_yc_IDj4VwW7npJ4tlvoCtJ9MNXPybpKtXv_54Qmvt_fD0ReTWwhn
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bSxwxFD6IQvWlWOplW7UR9HHc2Uwyl0UfpFXW64sK-xaTmUQW2tllZ5fii3_KP-g5c1latCCUfRsmCRm-JOcy5zsnAHt4wGQSOuGJtBN7QurE0yIl_pPLUL0HWaopUfjqOuzdifO-7C_Ac5MLQ7TKWvZXMr2U1vWbdo1mezQYtG_8mEJMYcRladj4NbPywj7-Rr-tODr7gYu8z_npye33nldfLeClQSgmnpaou4zwjcsSK-OQ8j-5jmyU6kxLE6PMdokNfatRhQr8FiFjbUzqDLonfkTVDlDuLwkUF3RtwsHTjFfCqaJ6abomVAsyjD7AbnWdbtCmNPJfxDAtpuMH9E15VTKUyJBvK8V_Gb2l8jtdhY-11cqOK2A-wYLNP0OvYtMMUuaGwwlraF150WXlb1R6xKYx0_mscVqwOiTEUkr-_EmXGK_B3VzQW4fFfJjbTWBOo_8ZS_QCrROoBIwf4ACHZhz245lpAW-QUaOq_oYq4-YyQL_lDzgVwan8jkI4W9BtMFRNgimKRIVa4j2Do7cG26I-3IXqqIIrX73agC04nI38aw-_d-LdZrkVnnEK3Ojc4sIotPEiKqrTwT4b1T6YgSHIKU14-OX_Jv8Gy73bq0t1eXZ98RVWqKVi2m3B4mQ8tdtoek3MTrnVGdzP-2y9AI94Qxg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diabetic+foot+infections%3A+Questions+for+an+infectious+disease+consultant&rft.jtitle=Seminars+in+vascular+surgery&rft.au=Nauriyal%2C+Varidhi&rft.au=Byers%2C+Karin&rft.date=2025-03-01&rft.issn=0895-7967&rft.volume=38&rft.issue=1&rft.spage=85&rft.epage=93&rft_id=info:doi/10.1053%2Fj.semvascsurg.2025.01.009&rft.externalDBID=n%2Fa&rft.externalDocID=10_1053_j_semvascsurg_2025_01_009
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08957967%2FS0895796725X00028%2Fcov150h.gif